Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
Abstract Objective The main goal of this work was to identify, describe, characterize, and classify the scientific evidence regarding the use of pharmacogenomic biomarkers in antidepressant treatment. Methods The work was developed in two phases: i) a search for pharmacogenomic biomarkers in summari...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-08-01
|
| Series: | BMC Psychiatry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12888-022-04225-2 |